OBR Green Articles (Lung (includes NSCLC, SCLC, Mesothelioma))


May 2018Edition

The data from AACR impressed this year. There were readouts from two big practice-changing lung cancer trials of competing IOs, and early stage studies exploring exciting new agents like BLU-667 and CMP-001 rounded out the highlights. In case you mis...


June 2018Edition

Can many women with early-stage breast cancer avoid chemotherapy and kidney cancer patients bypass surgery? New standards-of-care and possibly less radical treatment for patients was a key take-away from ASCO’s plenaries, where breakthroughs in fi...


March 2019Edition

OBR interviewed Dr. Mark Awad, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber, to get his perspective on some of the current lung cancer research taking place involving PD-L1, and the outlook for emerging biomarkers such as Tumor M...